Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Cigarette Smoking Exacerbates Skeletal Muscle Injury Without Compromising its Regenerative Capacity.

Chan SM, Cerni C, Passey S, Seow HJ, Bernardo I, van der Poel C, Dobric A, Brassington K, Selemidis S, Bozinovski S, Vlahos R.

Am J Respir Cell Mol Biol. 2019 Aug 28. doi: 10.1165/rcmb.2019-0106OC. [Epub ahead of print]

PMID:
31461300
2.

The human trithorax protein hASH2 functions as an oncoprotein.

Lüscher-Firzlaff J, Gawlista I, Vervoorts J, Kapelle K, Braunschweig T, Walsemann G, Rodgarkia-Schamberger C, Schuchlautz H, Dreschers S, Kremmer E, Lilischkis R, Cerni C, Wellmann A, Lüscher B.

Cancer Res. 2008 Feb 1;68(3):749-58. doi: 10.1158/0008-5472.CAN-07-3158.

3.

Oncogenic c-H-ras deregulates survivin expression: an improvement for survival.

Sommer KW, Rodgarkia-Dara CJ, Schreiner C, Holzmann K, Krupitza G, Cerni C.

FEBS Lett. 2007 Oct 16;581(25):4921-6. Epub 2007 Sep 21.

4.

Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.

Brachner A, Sasgary S, Pirker C, Rodgarkia C, Mikula M, Mikulits W, Bergmeister H, Setinek U, Wieser M, Chin SF, Caldas C, Micksche M, Cerni C, Berger W.

Cancer Res. 2006 Apr 1;66(7):3584-92.

5.

Truncated ALK derived from chromosomal translocation t(2;5)(p23;q35) binds to the SH3 domain of p85-PI3K.

Polgar D, Leisser C, Maier S, Strasser S, Rüger B, Dettke M, Khorchide M, Simonitsch I, Cerni C, Krupitza G.

Mutat Res. 2005 Feb 15;570(1):9-15.

PMID:
15680399
6.

PARP-10, a novel Myc-interacting protein with poly(ADP-ribose) polymerase activity, inhibits transformation.

Yu M, Schreek S, Cerni C, Schamberger C, Lesniewicz K, Poreba E, Vervoorts J, Walsemann G, Grötzinger J, Kremmer E, Mehraein Y, Mertsching J, Kraft R, Austen M, Lüscher-Firzlaff J, Lüscher B.

Oncogene. 2005 Mar 17;24(12):1982-93.

PMID:
15674325
7.

Caspase-9 plays a marginal role in serum starvation-induced apoptosis.

Schamberger CJ, Gerner C, Cerni C.

Exp Cell Res. 2005 Jan 1;302(1):115-28.

PMID:
15541731
8.

bFGF rescues 423-cells from serum starvation-induced apoptosis downstream of activated caspase-3.

Schamberger CJ, Gerner C, Cerni C.

FEBS Lett. 2004 Aug 27;573(1-3):19-25.

9.

Subcellular localisation of Cdc25A determines cell fate.

Leisser C, Rosenberger G, Maier S, Fuhrmann G, Grusch M, Strasser S, Huettenbrenner S, Fassl S, Polgar D, Krieger S, Cerni C, Hofer-Warbinek R, deMartin R, Krupitza G.

Cell Death Differ. 2004 Jan;11(1):80-9.

10.

Inhibitor of apoptosis protein (IAP) survivin is upregulated by oncogenic c-H-Ras.

Sommer KW, Schamberger CJ, Schmidt GE, Sasgary S, Cerni C.

Oncogene. 2003 Jul 3;22(27):4266-80.

PMID:
12833149
11.

Detection and quantification of transcripts for the catalytic subunit TERT and the RNA component of telomerase in rat tissue.

Holzmann K, Berger W, Mejri D, Cerni C, Sasgary S.

Anal Biochem. 2003 Jun 1;317(1):120-3. No abstract available.

PMID:
12729609
12.

Repression of in vivo growth of Myc/Ras transformed tumor cells by Mad1.

Cerni C, Skrzypek B, Popov N, Sasgary S, Schmidt G, Larsson LG, Lüscher B, Henriksson M.

Oncogene. 2002 Jan 17;21(3):447-59.

13.

Mapk/Sapk Signaling in Apoptosis and Bfgf-Mediated Survival.

Schamberger C, Cerni C.

ScientificWorldJournal. 2001 Nov 30;1:43. doi: 10.1100/tsw.2001.150. eCollection 2001. No abstract available.

14.

Processivity of C-Myc-Induced Telomerase Activation in Rat Cell Lines.

Sasgary S, Schmidt G, Skrzypek B, Cerni C.

ScientificWorldJournal. 2001 Nov 2;1:71. doi: 10.1100/tsw.2001.249. eCollection 2001. No abstract available.

15.

CDC25A Mediates Survival by Activating AKT Kinase.

Leisser C, Fuhrmann G, Rosenberger G, Grusch M, Halama T, Sasgary S, Cerni C, Krupitza G.

ScientificWorldJournal. 2001 Oct 12;1:94. doi: 10.1100/tsw.2001.213. eCollection 2001. No abstract available.

16.

Cdc25A phosphatase suppresses apoptosis induced by serum deprivation.

Fuhrmann G, Leisser C, Rosenberger G, Grusch M, Huettenbrenner S, Halama T, Mosberger I, Sasgary S, Cerni C, Krupitza G.

Oncogene. 2001 Jul 27;20(33):4542-53.

17.

Nuclear Ras: unexpected subcellular distribution of oncogenic forms.

Wurzer G, Mosgoeller W, Chabicovsky M, Cerni C, Wesierska-Gadek J.

J Cell Biochem Suppl. 2001;Suppl 36:1-11.

PMID:
11455565
18.

Targeted inhibition of telomerase in human cancer: will it be a double-edged sword?

Sasgary S, Wieser M, Cerni C.

Onkologie. 2001 Feb;24(1):22-6. Review.

PMID:
11441276
19.

The cytoplasmic truncated receptor tyrosine kinase ALK homodimer immortalizes and cooperates with ras in cellular transformation.

Simonitsch I, Polgar D, Hajek M, Duchek P, Skrzypek B, Fassl S, Lamprecht A, Schmidt G, Krupitza G, Cerni C.

FASEB J. 2001 Jun;15(8):1416-8. No abstract available.

PMID:
11387242
20.

Telomeres, telomerase, and myc. An update.

Cerni C.

Mutat Res. 2000 Jan;462(1):31-47. Review.

PMID:
10648922
21.

Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C.

Coulibaly S, Schwihla H, Abrahamson M, Albini A, Cerni C, Clark JL, Ng KM, Katunuma N, Schlappack O, Glössl J, Mach L.

Int J Cancer. 1999 Nov 12;83(4):526-31.

22.
23.

Expression of mouse RNase MRP RNA in human embryonic kidney 293 cells.

Rossmanith W, Bettinger E, Cerni C, Karwan RM.

Mol Biol Rep. 1997 Nov;24(4):221-30.

PMID:
9403864
24.

Oxidized low-density-lipoprotein triggers programmed death of endothelial cells.

Seelos C, Gmeiner B, Kapiotis S, Cerni C.

Biochem Mol Biol Int. 1997 Aug;42(5):1015-22.

PMID:
9285070
25.

Regulation of cell growth by the Myc-Max-Mad network: role of Mad proteins and YY1.

Austen M, Cerni C, Henriksson M, Hilfenhaus S, Lüscher-Firzlaff JM, Menkel A, Seelos C, Sommer A, Lüscher B.

Curr Top Microbiol Immunol. 1997;224:123-30. Review. No abstract available.

PMID:
9308235
26.

Induction of rat CD4+ proliferative and mouse CD8+ cytotoxic T-cell lines specific for human papillomavirus type 16 antigens.

Bagot M, Charue D, Cerni C, Revuz J, Meneguzzi G.

Res Virol. 1996 Sep-Oct;147(5):301-11.

PMID:
8880999
27.

ADP-ribosylation of wild-type p53 in vitro: binding of p53 protein to specific p53 consensus sequence prevents its modification.

Wesierska-Gadek J, Schmid G, Cerni C.

Biochem Biophys Res Commun. 1996 Jul 5;224(1):96-102.

PMID:
8694840
28.

ADP-ribosylation of p53 tumor suppressor protein: mutant but not wild-type p53 is modified.

Wesierska-Gadek J, Bugajska-Schretter A, Cerni C.

J Cell Biochem. 1996 Jul;62(1):90-101.

PMID:
8836878
29.

Differential effects by Mad and Max on transformation by cellular and viral oncoproteins.

Cerni C, Bousset K, Seelos C, Burkhardt H, Henriksson M, Lüscher B.

Oncogene. 1995 Aug 3;11(3):587-96.

PMID:
7630643
30.
32.
33.

Successive steps in the process of immortalization identified by transfer of separate bovine papillomavirus genes into rat fibroblasts.

Cerni C, Binétruy B, Schiller JT, Lowy DR, Meneguzzi G, Cuzin F.

Proc Natl Acad Sci U S A. 1989 May;86(9):3266-70.

34.
35.
37.

Biological effects of high level c-myc expression in FR3T3 fibroblasts.

Zerlin M, Julius MA, Cerni C, Marcu KB.

Curr Top Microbiol Immunol. 1986;132:320-6. No abstract available.

PMID:
3792040
38.

c-myc and functionally related oncogenes induce both high rates of sister chromatid exchange and abnormal karyotypes in rat fibroblasts.

Cerni C, Mougneau E, Zerlin M, Julius M, Marcu KB, Cuzin F.

Curr Top Microbiol Immunol. 1986;132:193-201. No abstract available.

PMID:
3792034
39.

Genetic instabilities at the chromosomal and the molecular levels induced by the plt oncogene of polyoma virus.

Léopold P, Mougneau E, Vailly J, Cerni C, Rassoulzadegan M, Cuzin F.

Ann Clin Res. 1986;18(5-6):304-6. No abstract available.

PMID:
3032066
40.

Sister chromatid exchange in FR3T3 rat fibroblasts transformed by Simian virus 40.

Cerni C, Mougneau E.

Exp Cell Res. 1984 Sep;154(1):83-94.

PMID:
6088264
41.
44.
45.

Lymphocyte transformation and isovolemic hemodilution with hydroxyethylstarch 450,000.

Khosropour R, Cerni C, Lackner F, Wagner O, Watzek C, Amesberger C.

Infusionsther Klin Ernahr. 1983 Apr;10(2):100-2.

PMID:
6190750
46.

Indication of reduced doxorubicin-induced cardiac toxicity by additional treatment with antioxidative substances.

Lenzhofer R, Magometschnigg D, Dudczak R, Cerni C, Bolebruch C, Moser K.

Experientia. 1983 Jan 15;39(1):62-4.

PMID:
6825779
47.

[Effect of dextran 60,000(D 60) and hydroxyethyl starch 450,000 (HES 450) on lymphocyte transformation].

Khosropour R, Cerni C, Lackner F, Watzek C.

Anaesthesist. 1983 Jan;32(1):25-7. German.

PMID:
6189413
48.

[Results of a comparative therapy study for inoperable lung cancer].

Kokron O, Alth G, Cerni C, Denck H, Fischer M, Karrer K, Micksche M, Ogris E, Titscher R, Wrba H.

Onkologie. 1982 Feb;5(1):20-2. German.

PMID:
7041031
49.
50.

Failure of somatostatin to influence experimental tumor cell growth in vivo and in vitro.

Lenzhofer R, Cerni C, Fröhlich I, Prager J, Pointner H.

Experientia. 1981;37(9):1015-7.

PMID:
6117474

Supplemental Content

Support Center